SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-008213
Filing Date
2020-03-31
Accepted
2020-03-31 16:15:22
Documents
1
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4230
  Complete submission text file 0001213900-20-008213.txt   5627
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 SAN MATEO DR MENLO PARK CA 94025
Business Address
Brown Dennis M (Reporting) CIK: 0001569520 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 20761961